INVITROCUE
Company Snapshot
Founded: 2012
Entity Type: Private
Region: Singapore
Headquarter: Singapore
Key Geographics: Singapore, Germany, Spain, Brazil, Australia, China, Hong Kong
Corporate Address: 51 Science Park Road, #01-11/13 The Aries Singapore Science Park II Singapore 117586 Singapore Tel. +65-6460-0497 www.invitrocue.com
Company Overview
Invitrocue is a leading provider of bio-analytic solutions, including in vitro cell-based testing technologies and image analytics software for use in digital pathology. Invitrocue has developed a 3D cell-based scaffolding technology that mimics human organ samples for use in the field of infectious diseases., The company expanded its work in liver disease to the field of oncology. The technology enables patient-derived cancer cells (organoids) to be cultured in laboratories for testing against a panel of drugs to support clinical decision making for personalized medicine.
Invitrocue from Singapore's A*STAR offers in vitro DMPK and toxicology services validated with top biopharmaceutical companies. It utilizes patented models, includin
INVITROCUE In News
Company's Business Segments
- Products : The company generates revenue from the oncology product segment: Onco-PDO test.
- Services : Drug Metabolism and Pharmacokinetics, Toxicology and Safety Assessment, Hepatocytes, 3D Cell Culture, Customized Assays and Disease Modelling, Invivocue’s HiMice.
Applications/End User Industries
- Healthcare
- Biotechnology
- Life Sciences
- Research Institutions
BCC Research Beacon 